Results 171 to 180 of about 1,482,753 (199)
Some of the next articles are maybe not open access.

Pharmacotherapy for Treatment of Tobacco Use Disorder

Journal of Psychosocial Nursing and Mental Health Services, 2023
Tobacco use disorder (TUD), the leading cause of preventable deaths in the United States, disproportionally impacts those with psychiatric disorders. There are multiple first-line, U.S. Food and Drug Administration–approved pharmacotherapy options for the treatment of TUD.
openaire   +2 more sources

Investigation of Catechol-O-Methyltransferase and Cannabinoid Receptor 2 gene variants in tobacco use disorder or tobacco use disorder and schizophrenia comorbidity

, 2020
Objective: The purpose of this study was to investigate whether functional variants of Catechol-O-Methyltrans-ferase (COMT) (rs4680) and Cannabinoid Receptor 2 (CNR2) (rs2501432) genes play a role in tobacco use disor-der (TUD) or tobacco use disorder ...
S. Pehlivan   +5 more
semanticscholar   +1 more source

Tobacco and alcohol use disorders: Evaluating multimorbidity

Addictive Behaviors, 2018
There is growing interest in applying the multimorbidity model for mental health disorders - i.e. the interactive effects of co-occurring diagnoses. Alcohol use disorder (AUD) and tobacco use disorder (TUD) often occur together, but distinctive correlates of their co-occurrence have not been studied.
R. Ross MacLean   +2 more
openaire   +2 more sources

Association of Semaglutide With Tobacco Use Disorder in Patients With Type 2 Diabetes

Annals of Internal Medicine
BACKGROUND Reports of reduced desire to smoke in patients treated with semaglutide, a glucagon-like peptide receptor agonist (GLP-1RA) medication for type 2 diabetes mellitus (T2DM) and obesity, have raised interest about its potential benefit for ...
William Wang   +5 more
semanticscholar   +1 more source

Strategies for Prevention or Treatment of Tobacco and Cannabis Use Disorder

Clinical Obstetrics & Gynecology, 2022
Tobacco and cannabis use in pregnancy are associated with increased adverse perinatal and long-term offspring outcomes. Products for both have evolved with various forms available on the market, challenging accurate counseling of risks and quantification of tobacco and cannabis usage during the perinatal period. Health care providers are recommended to
Katherine N, DeJong   +2 more
openaire   +2 more sources

Tobacco Use Disorder

2017
Among smokers, approximately half meet criteria for tobacco use disorder, the formal psychiatric diagnosis of addiction to nicotine, making it among the most prevalent of all psychiatric disorders. Minimal contact interventions (MCIs) are intended for a wide variety of healthcare professionals, including psychologists, psychiatrists, primary care ...
James MacKillop   +4 more
openaire   +2 more sources

Alcohol, Tobacco, and Drug Use Disorders and Personality Disorder Symptoms.

Experimental and Clinical Psychopharmacology, 2004
In a nonclinical sample of 395 young adults, the authors evaluated the relations between major personality traits, Diagnostic and Statistical Manual of Mental Disorders (4th ed.; DSM-IV; American Psychiatric Association, 1994) personality disorder symptoms, and DSM-IV alcohol use disorders (AUDs).
Kenneth J. Sher   +2 more
openaire   +3 more sources

Treatment of Tobacco Use Disorder and Mood Disorders in Adolescents

Current Addiction Reports, 2018
To update the literature on treatment of tobacco use in the context of comorbid mood disorders among adolescents, focusing on the last 5 years (2013–2017). We review tobacco use prevalence, the association between adolescent tobacco use and mood disorders, and interventions for adolescent tobacco users and those with concurrent mood disorders. Advances
Christi A. Patten, Daniel R. Witt
openaire   +2 more sources

Prospective analysis of comorbidity: Tobacco and alcohol use disorders.

Journal of Abnormal Psychology, 2000
Alcohol use disorders (AUD) and tobacco use disorders (TD) frequently co-occur. The authors examined AUD-TD comorbidity over time using a state-trait (ST) model. The ST model represents variance in AUD/TD as a traitlike factor that spans measurement occasion and identifies distinct sources of variance in AUD-TD comorbidity.
Kristina M. Jackson   +2 more
openaire   +3 more sources

Tobacco-free grounds implementation in California residential substance use disorder (SUD) treatment programs

Journal of Addictive Diseases, 2020
Smoke-free laws and policies have contributed significantly to the decline in smoking in the U.S, but are not often applied in high-prevalence smoking populations where they are most needed. Smoking among clients in publicly funded substance use disorder
J. Guydish   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy